Literature DB >> 20027044

Second-trimester amniotic fluid proinflammatory cytokine levels in normal and overweight women.

Fernando Bugatto1, Álvaro Fernández-Deudero, Ángeles Bailén, Rosa Fernández-Macías, Blas Hervías-Vivancos, José L Bartha.   

Abstract

OBJECTIVE: To estimate the relationship between different adipokines and proinflammatory mediators in amniotic fluid and maternal body mass index (BMI), calculated as weight (kg)/height (m)2.
METHODS: Seventy pregnant women who underwent amniocentesis for clinical reasons at 15-20 weeks of gestation were divided into two groups according to their BMI: a control group with normal weight (BMI 20-24.9, n=35) and a case group (BMI 25 or higher, n=35). The two groups were further divided into two subgroups: overweight (BMI 25-29.9, n=22) or obese (BMI 30 or more, n=13). Comparisons of amniotic fluid cytokines (tumor necrosis factor [TNF]-alpha, interleukin [IL]-8, IL-10, monocyte chemoattractant protein-1, resistin, and leptin) and C-reactive protein (CRP) levels were performed. The relationships between variables and maternal BMI were also analyzed.
RESULTS: There were significant differences in amniotic fluid CRP and TNF-alpha levels among the studied groups: CRP, 0.018 (+/-0.010), 0.019 (+/-0.013), and 0.035 (+/-0.028) mg/dL (P=.007); and TNF-alpha, 3.98 (+/-1.63), 3.53 (+/-1.38), and 5.46 (+/-1.69) pg/mL (P=.003), for lean, overweight, and obese women, respectively. Both proinflammatory mediators increased in women with obesity compared with both overweight and normal women (P=.01 and P=.008 for CRP; P=.003 and P=.01 for TNF-alpha, respectively). There were significant correlations between maternal BMI and amniotic fluid CRP (r=0.396; P=.001), TNF-alpha (r=0.357; P=.003) and resistin (r=0.353; P=.003).
CONCLUSION: Amniotic fluid CRP and TNF-alpha levels are increased in obese women, and both are related to maternal BMI, which suggests in utero exposure to higher proinflammatory cytokines and mediators in fetuses of these women. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20027044     DOI: 10.1097/AOG.0b013e3181c5367f

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Maternal Pre-pregnancy Body Mass Index and Autism Spectrum Disorder among Offspring: A Population-Based Case-Control Study.

Authors:  Kelly D Getz; Marlene T Anderka; Martha M Werler; Susan S Jick
Journal:  Paediatr Perinat Epidemiol       Date:  2016-05-30       Impact factor: 3.980

2.  Maternal body mass index: Relation with infant respiratory symptoms and infections.

Authors:  Ashley Rajappan; Anna Pearce; Hazel M Inskip; Janis Baird; Sarah R Crozier; Cyrus Cooper; Keith M Godfrey; Graham Roberts; Jane S A Lucas; Katharine C Pike
Journal:  Pediatr Pulmonol       Date:  2017-08-16

3.  Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid.

Authors:  Tobias Weissenbacher; Rüdiger P Laubender; Steven S Witkin; Andrea Gingelmaier; Barbara Schiessl; Franziskus Kainer; Klaus Friese; Udo Jeschke; Darius Dian; Katrin Karl
Journal:  BMC Res Notes       Date:  2012-07-24

4.  TNFα-Induced Oxidative Stress and Mitochondrial Dysfunction Alter Hypothalamic Neurogenesis and Promote Appetite Versus Satiety Neuropeptide Expression in Mice.

Authors:  Mina Desai; Linsey Stiles; Adriana S Torsoni; Marcio A Torsoni; Orian S Shirihai; Michael G Ross
Journal:  Brain Sci       Date:  2022-07-09

5.  Changes in the biochemical and immunological components of serum and colostrum of overweight and obese mothers.

Authors:  Mahmi Fujimori; Eduardo L França; Vanessa Fiorin; Tassiane C Morais; Adenilda C Honorio-França; Luiz C de Abreu
Journal:  BMC Pregnancy Childbirth       Date:  2015-08-12       Impact factor: 3.007

6.  Amniotic fluid exerts a neurotrophic influence on fetal neurodevelopment via the ERK/GSK-3 pathway.

Authors:  Yongwoo Jang; Eun-Kyung Kim; Won-Sik Shim; Ki-Min Song; Sung Min Kim
Journal:  Biol Res       Date:  2015-08-05       Impact factor: 5.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.